The global creatinine measurement market projected to grow at a CAGR of 8.4%.
Factors such as the increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, favorable government initiatives to promote renal health, rapid growth in the geriatric population, and the increasing number of drug development initiatives are driving the growth of the creatinine test kits and reagents market. On the other hand, identification of novel renal dysfunction biomarkers and frequently changing regulatory policies are expected to restrain the growth of this market to a certain extent.
Enzymatic method is expected to grow at the highest CAGR during the forecast period.
Based on test type, the market is segmented into is segmented into Jaffe’s kinetic method and enzymatic method. The enzymatic method segment is expected to grow at the highest CAGR during the forecast period owing to the advantages offered by this method such as high accuracy and specificity, low sample volume, and lack of interfering substances.
Blood/serum is expected to dominate the market during the forecast period.
Based on type of sample the creatinine measurement market is segmented into blood/serum and urine samples. The blood/serum segment is expected to hold the largest share of the market and is also projected to grow at the highest CAGR during the forecast period. The large share of the blood/serum segment is primarily attributed to the benefits offered by this sample type, such as increased accuracy and low risk of contamination.
In 2018, hospitals segment is expected to account for the largest share of the market.
On the basis of end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. In 2018, the hospitals segment is expected to account for the largest share of the creatinine measurement market. High patient influx, regular monitoring of kidney function by physicians (of patients with various disorders impacting kidney function) at hospitals, and the presence of an established and advanced diagnostic infrastructure are some of the major factors responsible for the large share of this end-user segment.
Asia to witness the highest growth during the forecast period.
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The growing prevalence of CKD, rising awareness about preventive healthcare, improving healthcare infrastructure, and growing focus of market players on addressing the demands in several Asian countries are the key factors driving the market growth in Asia. Also, as developed markets are reaching saturation levels, Asia is expected to become a hotspot for creatinine test kit providers.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 – 32%; Tier 2 - 44%; Tier 3 - 24%
- By Designation C-level- 23%; D-level- 26%; Others- 51%
- By Region: North America-59%; Europe-14%; Asia -22%; Rest of the World-5%
List of companies profiled in the report
- F. Hoffmann-la Roche Ltd (Switzerland)
- Abbott Laboratories (US)
- Danaher Corporation (US)
- Thermo Fisher Scientific Inc (US)
- Siemens Healthineers (Germany)
- Randox Laboratories (UK)
- Pointe Scientific, Inc (US)
- Sentinel Ch. Spa. (Italy)
- Diasys Diagnostic Systems GmbH (Germany)
- Dialab GmbH (Vienna)
- Diazyme Laboratories, Inc (US)
- Wako Pure Chemical Industries Ltd (Japan)
- Ortho Clinical Diagnostics (US)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
Research Coverage:
The report provides an overview of the creatinine measurement market. It aims at estimating the market size and future growth potential of this market across different segments such as test type, type of sample, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall creatinine measurement market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.
Table of Contents
1 Introduction
2 Research Methodology
5 Market Overview
6 Creatinine Test Kits and Reagents Market, By Product
7 Creatinine Test Kits and Reagents Market, By Type
8 Creatinine Test Kits and Reagents Market, By Sample Type
9 Creatinine Test Kits and Reagents Market, By End User
10 Creatinine Test Kits and Reagents Market, By Region
11 Competitive Landscape
12 Company Profiles
13 Appendix
List of Tables (96 Tables)
List of Figures (21 Figures)
Companies Mentioned
- Abbott Laboratories (US)
- Danaher Corporation (US)
- Dialab GmbH (Vienna)
- Diasys Diagnostic Systems GmbH (Germany)
- Diazyme Laboratories, Inc (US)
- F. Hoffmann-la Roche Ltd (Switzerland)
- Ortho Clinical Diagnostics (US)
- Pointe Scientific, Inc (US)
- Randox Laboratories (UK)
- Sentinel Ch. Spa. (Italy)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
- Siemens Healthineers (Germany)
- Thermo Fisher Scientific Inc (US)
- Wako Pure Chemical Industries Ltd (Japan)
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | June 2018 |
| Forecast Period | 2018 - 2023 |
| Estimated Market Value ( USD | $ 377.2 million |
| Forecasted Market Value ( USD | $ 564.5 million |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 14 |
